Ascendis Pharma
ASND
ASND
164 hedge funds and large institutions have $6.54B invested in Ascendis Pharma in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 58 increasing their positions, 65 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $8.05B → $6.54B (-$1.51B)
35% less funds holding in top 10
Funds holding in top 10: 20 → 13 (-7)
57% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 37
Holders
164
Holding in Top 10
13
Calls
$117M
Puts
$22.8M
Top Buyers
| 1 | +$69.2M | |
| 2 | +$45.2M | |
| 3 | +$42.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$24.1M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$22.5M |
Top Sellers
| 1 | -$605M | |
| 2 | -$85.5M | |
| 3 | -$36.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$14.5M |